247 related articles for article (PubMed ID: 36278951)
41. Electrocardiographic features and rhythm disorders in cardiac amyloidosis.
Martini N; Sinigiani G; De Michieli L; Mussinelli R; Perazzolo Marra M; Iliceto S; Zorzi A; Perlini S; Corrado D; Cipriani A
Trends Cardiovasc Med; 2024 May; 34(4):257-264. PubMed ID: 36841466
[TBL] [Abstract][Full Text] [Related]
42. A strange case of Transthyretin Cardiac Amyloidosis in the Elderly: a diagnostic challenge.
Simeone B; Zuchi C; Mengoni A; Carluccio E; Biagioli P; Lauciello R; Sasso G; Scavelli F; Rocco E; Ambrosio G
Clin Ter; 2023; 174(3):235-239. PubMed ID: 37199356
[TBL] [Abstract][Full Text] [Related]
43. Clinical profile and outcome of cardiac amyloidosis in a Spanish referral center.
López-Sainz Á; Hernandez-Hernandez A; Gonzalez-Lopez E; Domínguez F; Restrepo-Cordoba MA; Cobo-Marcos M; Gómez-Bueno M; Hernandez-Perez FJ; Oteo JF; Mirelis JG; Cavero MA; Moñivas V; Mingo Santos S; de Haro-Del Moral FJ; Krsnik I; Salas C; Bornstein B; Briceño A; López JA; Vázquez J; Alonso-Pulpón L; Segovia J; Garcia-Pavia P
Rev Esp Cardiol (Engl Ed); 2021 Feb; 74(2):149-158. PubMed ID: 32317158
[TBL] [Abstract][Full Text] [Related]
44. Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies.
Aimo A; Merlo M; Porcari A; Georgiopoulos G; Pagura L; Vergaro G; Sinagra G; Emdin M; Rapezzi C
Eur J Heart Fail; 2022 Dec; 24(12):2342-2351. PubMed ID: 35509173
[TBL] [Abstract][Full Text] [Related]
45. Cardiac Amyloidosis: Presentations, Diagnostic Work-up and Collaborative Approach for Comprehensive Clinical Management.
Joury A; Gupta T; Krim SR
Curr Probl Cardiol; 2021 Oct; 46(10):100910. PubMed ID: 34175153
[TBL] [Abstract][Full Text] [Related]
46. Subtype-Specific Interactions and Prognosis in Cardiac Amyloidosis.
Sperry BW; Vranian MN; Hachamovitch R; Joshi H; Ikram A; Phelan D; Hanna M
J Am Heart Assoc; 2016 Mar; 5(3):e002877. PubMed ID: 27013539
[TBL] [Abstract][Full Text] [Related]
47. Addressing Common Questions Encountered in the Diagnosis and Management of Cardiac Amyloidosis.
Maurer MS; Elliott P; Comenzo R; Semigran M; Rapezzi C
Circulation; 2017 Apr; 135(14):1357-1377. PubMed ID: 28373528
[TBL] [Abstract][Full Text] [Related]
48. Cardiac amyloidosis.
Yusuf SW; Solhpour A; Banchs J; Lopez-Mattei JC; Durand JB; Iliescu C; Hassan SA; Qazilbash MH
Expert Rev Cardiovasc Ther; 2014 Feb; 12(2):265-77. PubMed ID: 24386926
[TBL] [Abstract][Full Text] [Related]
49. Cardiac amyloidosis: a review and report of a new transthyretin (prealbumin) variant.
Hesse A; Altland K; Linke RP; Almeida MR; Saraiva MJ; Steinmetz A; Maisch B
Br Heart J; 1993 Aug; 70(2):111-5. PubMed ID: 8038017
[TBL] [Abstract][Full Text] [Related]
50. Cardiac transthyretin amyloidosis.
Dungu JN; Anderson LJ; Whelan CJ; Hawkins PN
Heart; 2012 Nov; 98(21):1546-54. PubMed ID: 22888163
[TBL] [Abstract][Full Text] [Related]
51. Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy.
Bennani Smires Y; Victor G; Ribes D; Berry M; Cognet T; Méjean S; Huart A; Roussel M; Petermann A; Roncalli J; Carrié D; Rousseau H; Berry I; Chauveau D; Galinier M; Lairez O
Int J Cardiovasc Imaging; 2016 Sep; 32(9):1403-1413. PubMed ID: 27240600
[TBL] [Abstract][Full Text] [Related]
52. Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS).
Ruberg FL; Maurer MS; Judge DP; Zeldenrust S; Skinner M; Kim AY; Falk RH; Cheung KN; Patel AR; Pano A; Packman J; Grogan DR
Am Heart J; 2012 Aug; 164(2):222-228.e1. PubMed ID: 22877808
[TBL] [Abstract][Full Text] [Related]
53. Newer Therapies for Amyloid Cardiomyopathy.
Chakraborty R; Muchtar E; Gertz MA
Curr Heart Fail Rep; 2016 Oct; 13(5):237-246. PubMed ID: 27497715
[TBL] [Abstract][Full Text] [Related]
54. Cardiac Amyloidosis Treatment.
Stern LK; Patel J
Methodist Debakey Cardiovasc J; 2022; 18(2):59-72. PubMed ID: 35414852
[TBL] [Abstract][Full Text] [Related]
55. Cardiac amyloidosis - experience in a tertiary cardiac referral centre.
Chau EM; Chow WH; Wang E; Kwong YL
Int J Cardiol; 2008 Feb; 124(2):264-6. PubMed ID: 17383027
[TBL] [Abstract][Full Text] [Related]
56. Outcomes in Patients With Cardiac Amyloidosis Undergoing Heart Transplantation.
Barrett CD; Alexander KM; Zhao H; Haddad F; Cheng P; Liao R; Wheeler MT; Liedtke M; Schrier S; Arai S; Weisshaar D; Witteles RM
JACC Heart Fail; 2020 Jun; 8(6):461-468. PubMed ID: 32387068
[TBL] [Abstract][Full Text] [Related]
57. Updates for the diagnosis and management of cardiac amyloidosis.
Gościniak P; Baron T; Milczarek S; Kostkiewicz M; Machaliński B
Adv Clin Exp Med; 2022 Feb; 31(2):175-185. PubMed ID: 35195962
[TBL] [Abstract][Full Text] [Related]
58. A novel variant of transthyretin, 59Thr-->Lys, associated with autosomal dominant cardiac amyloidosis in an Italian family.
Booth DR; Tan SY; Hawkins PN; Pepys MB; Frustaci A
Circulation; 1995 Feb; 91(4):962-7. PubMed ID: 7850982
[TBL] [Abstract][Full Text] [Related]
59. Editorial commentary: Heart rate and rhythm in cardiac amyloidosis.
Sperry BW; Sandesara UB; Kline JA
Trends Cardiovasc Med; 2024 May; 34(4):254-256. PubMed ID: 36977449
[No Abstract] [Full Text] [Related]
60. Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review.
Ruberg FL; Grogan M; Hanna M; Kelly JW; Maurer MS
J Am Coll Cardiol; 2019 Jun; 73(22):2872-2891. PubMed ID: 31171094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
